Gd Searle Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GD SEARLE LLC, and what generic and branded alternatives to GD SEARLE LLC drugs are available?
GD SEARLE LLC has twenty-seven approved drugs.
Drugs and US Patents for Gd Searle Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gd Searle Llc | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | CAPSULE;ORAL | 071728-001 | Dec 18, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Gd Searle Llc | OVULEN | ethynodiol diacetate; mestranol | TABLET;ORAL-20 | 016029-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Gd Searle Llc | ENOVID-E | mestranol; norethynodrel | TABLET;ORAL-20 | 010976-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Gd Searle Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Gd Searle Llc | CU-7 | copper | INTRAUTERINE DEVICE;INTRAUTERINE | 017408-001 | Approved Prior to Jan 1, 1982 | RE28399 | ⤷ Sign Up |
Gd Searle Llc | TATUM-T | copper | INTRAUTERINE DEVICE;INTRAUTERINE | 018205-001 | Approved Prior to Jan 1, 1982 | 3,563,235 | ⤷ Sign Up |
Gd Searle Llc | CU-7 | copper | INTRAUTERINE DEVICE;INTRAUTERINE | 017408-001 | Approved Prior to Jan 1, 1982 | 3,563,235 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.